Dynavax Technologies Corporation
Dynavax Technologies Corporation, commonly referred to as Dynavax, is a prominent biopharmaceutical company headquartered in the United States. Founded in 1996, Dynavax has established itself in the immunotherapy sector, focusing on the development of innovative therapies for infectious diseases and cancer.
The company is renowned for its flagship product, HEPLISAV-B, a unique hepatitis B vaccine that offers enhanced protection with a two-dose regimen. This product exemplifies Dynavax's commitment to advancing vaccine technology and improving patient outcomes.
With a strong market position, Dynavax has achieved significant milestones, including successful collaborations and partnerships that bolster its research and development efforts. The company continues to expand its operational footprint, contributing to the evolving landscape of immunology and infectious disease management.
+62 vs industry average
Dynavax Technologies Corporation’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Dynavax Technologies Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Dynavax Technologies Corporation yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Dynavax Technologies Corporation’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Dynavax Technologies Corporation yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Sanofi
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from SanofiRE 100
Inherited from SanofiClimate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project